Key result
Resveratrol improves cardiovascular function in diabetic rats with MI via eNOS, VEGF, and p38 MAPK.
Why the study?
The protective effect of resveratrol on cardiovascular function in rats with diabetes-related myocardial infarction was evaluated.
Does resveratrol improve cardiovascular function in rats with diabetes-related myocardial infarction?
Population
Rats with diabetes-related myocardial infarction
Comparison
Resveratrol treatment vs no treatment
Design
Preclinical experimental study
Authors
Loading...
Resveratrol may improve CV function in diabetic rat models; leaves open clinical translation to humans.
Does resveratrol improve cardiovascular function in rats with diabetes-related myocardial infarction?
p-value: p=<0.01
Resveratrol improves cardiovascular function and metabolic parameters in a rat model of diabetes-related myocardial infarction by modulating eNOS, VEGF, and p38 pathways.
Yan et al. (2017) studied Diabetes-related myocardial infarction (n=46). Resveratrol vs. Normal saline was evaluated on Blood glucose, plasma triglyceride levels, heart rate, and AST/ALT ratio (p=<0.01). Resveratrol significantly reduced blood glucose, plasma triglycerides, and heart rate, and improved cardiovascular function via modulation of eNOS, VEGF, and p38 MAPK in rats with diabetes-related myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: